Philip Ward is ACT's European editor, phone +44 1244 538583, firstname.lastname@example.org
What Can You Do to Prevent Clinical Trial Fraud?
Expert outlines approaches to preventing fraud in clinical research-a more prevalent problem that many believe.
EFPIA Voices Fresh Concerns on EMA Relocation
Decision on EMA Relocation is Due on November 20
DIA Jumps on Brexit Bandwagon
EU Trials Register Now Holds Data on Over 50k Studies
Swiss Look to Expand Pediatric Trials
EFGCP Gives Priority to ‘Two Ends of Life’
Europe’s Battle to Host EMA Post-Brexit Intensifies
Vienna joins growing list of bidders to land Europe's drug regulator; Amsterdam the early favorite?
Ergomed Reveals Expansion Plan in Orphan Drugs
EFPIA Report Pinpoints Risks From EMA Relocation
MHRA Requests Feedback Ahead of Brexit
Assero and S-Cubed create A3 Informatics
Europe and U.S. Regulators Increase Cooperation on Inspections
EFGCP Steps Up Search for COO
EMA Prepares for Brexit
Include Pregnant Women in Trials, Urge Researchers
Pressure is growing on clinical trial organizers to involve more pregnant women in drug research.
Deadline Looms for Applications to Host EMA
EMA Revises Guideline On First-in-Human Trials
EMA’s Relocation Poses Serious Threat to Pharmacovigilance Experts
European experts in postmarking safety surveillance have the most to loose from impending EMA move post-Brexit.
Industry Bosses Call for Swift Action on EMA Relocation
In an open letter issued this week, the heads of research and development from several big pharma companies and the EFPIA have demanded a quick decision on the relocation of the EMA.
EMA Reviews Public Communication Strategy
The EMA has unveiled a new survey to assess how its communication strategy to the general public is perceived and valued by its stakeholders.
RAPS Seeks to Raise its Profile in Europe
The Regulatory Affairs Professionals Society (RAPS) is seeking to increase its presence in Europe and expanding its European team.
Industry Draws Up Action Plan on Brexit
The global skills shortage in the clinical research sector is being exacerbated in the U.K. by the uncertainty created by Brexit.
Synexus and Radiant Research Announce Merger
Synexus and Radiant Research are merging their operations to form a single global site network of 185 sites with 1,500 employees.
EMA Seeks to Promote Collaboration with Academia
The European Medicines Agency (EMA) has developed a three-year plan to formalize, structure and develop interactions with the academic community.
EFGCP Puts Renewed Emphasis on Complex Studies
The European Forum for Good Clinical Practice to examine the impact of current regulations and areas such as big data and quality management on so-called complex studies.
Women Prefer HIV Trials They Discover Through Peers
Women are often underrepresented in HIV clinical trials, but they appear to prefer finding out about trials by means of peer-to-peer communication, according to new analysis.
Special Clinical Research Summit on Brexit Set for April
An emergency summit to discuss how to safeguard the clinical research industry in the U.K. before and after Brexit will take place on April 5.
European and U.S. Regulators Agree on Mutual Recognition of Inspections
Regulators in the European Union (EU) and the U.S. have agreed to recognize inspections of manufacturing sites for human medicines conducted in their respective territories on both sides of the Atlantic.
EFPIA Unveils Nathalie Moll as New Director General
The EFPIA has revealed the appointment of Nathalie Moll as its new director general.
2 Clarke Drive Cranbury, NJ 08512